Enveric Biosciences, Inc. (NASDAQ:ENVB – Get Free Report)’s stock price was down 3.9% during trading on Tuesday . The stock traded as low as $1.62 and last traded at $1.74. Approximately 1,932,142 shares were traded during trading, an increase of 472% from the average daily volume of 337,854 shares. The stock had previously closed at $1.81.
Enveric Biosciences Price Performance
The stock has a market cap of $1.18 million, a price-to-earnings ratio of -0.05 and a beta of 0.55. The firm has a 50 day simple moving average of $5.01 and a two-hundred day simple moving average of $6.42.
Enveric Biosciences Company Profile
Enveric Biosciences, Inc, a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health.
See Also
- Five stocks we like better than Enveric Biosciences
- Find and Profitably Trade Stocks at 52-Week Lows
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- What Do S&P 500 Stocks Tell Investors About the Market?
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- What is a Special Dividend?
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Enveric Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enveric Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.